Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    "Berger disease"
Show Display Options
Rank Status Study
1 Completed Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis, IGA;   Nephropathy, IGA;   IGA Nephropathy
Interventions: Drug: ACE inhibitor + statin;   Drug: Sirolimus (study drug)+ACE inhibitor + statin
2 Not yet recruiting Efficacy and Safety of Atacicept in IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: atacicept 25 mg;   Drug: atacicept 75 mg;   Drug: atacicept 150 mg;   Drug: Placebo
3 Completed Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Procedure: gene transcription and cytometry
4 Completed A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
5 Completed Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Condition: IGA Nephropathy
6 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
7 Recruiting Acthar on Proteinuria in IgA Nephropathy Patients
Conditions: IgA Nephropathy;   Proteinuria
Intervention: Drug: Acthar 80 unit injection
8 Completed
Has Results
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: allopurinol;   Other: continue their usual therapy
9 Suspended Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Procedure: tonsillectomy;   Other: non-tonsillectomy
10 Completed A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
Condition: IgA Nephropathy
11 Recruiting Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: Losartan;   Drug: Abelmoschus manihot
12 Active, not recruiting Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
Condition: IgA Nephropathy
Interventions: Drug: irbesartan;   Drug: methylprednisolone (MP) or prednisone (pred);   Drug: mycophenolate mofetil (MMF)
13 Completed An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
Condition: IgA Nephropathy
14 Active, not recruiting Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Study)
Condition: IgA Glomerulonephritis
Interventions: Drug: methylprednisolone;   Drug: Placebo
15 Terminated Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Conditions: IGA Nephropathy;   Proteinuria
Intervention: Biological: OPL-CCL2-LPM
16 Not yet recruiting Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: Prednisolone;   Drug: Reh-acteoside
17 Recruiting Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: prednisone plus cyclophosphamide;   Drug: Prednisone alone
18 Completed Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Mycophenolate mofetil
19 Recruiting Trial of Plasma Exchange for Severe Crescentic IgA NEphropathy
Conditions: Glomerulonephritis, IGA;   Kidney Diseases;   Acute Renal Insufficiency;   Rapidly Progressive Glomerulonephritis
Interventions: Procedure: Plasma Exchange (PE);   Drug: Methylprednisolone pulse
20 Recruiting Rituximab in Recurrent IgA Nephropathy
Condition: Recurrent IgA Nephropathy
Interventions: Drug: Intravenous Rituximab;   Drug: ACEI/ARB and corticosteroids

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years